Scholars Central

Mini reviewPublished 15 May 2024

Mid-level Molecular Phenotypes for the Identification of Genetic Signatures of Anthracycline-induced Cardiotoxicity Hazard

Authors: Cardinale Goldstein

Human Genetics & Embryology

Volume 15 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Anthracyclines are a class of chemotherapy drugs widely used in cancer treatment. Despite their efficacy, anthracyclines are associated with a significant risk of cardiotoxicity, which can lead to heart failure. Identifying genetic signatures associated with Anthracycline-Induced Cardiotoxicity (AIC) is crucial for predicting which patients are at higher risk and for developing preventive strategies. Mid-level molecular phenotypes, which encompass changes in gene expression, protein levels, and metabolite concentrations, offer a promising approach for identifying these genetic signatures. This review discusses the integration of mid-level molecular phenotypes with genetic data to uncover biomarkers of AIC hazard. We explore the current methodologies, highlight key findings, and propose future directions for research in this field.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHuman Genetics & Embryology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Cardinale Goldstein”